LakeShore Biopharma receives Nasdaq delisting determination letter

Anixa Biosciences completes dosing of fourth cohort in ovarian cancer CAR-T trial; Early results show promise

ExpreS2ion reports early immune response in first patient from Phase I HER2 breast cancer vaccine trial

Valneva reports strong Phase 2 booster results for Lyme disease vaccine candidate VLA15

GC Biopharma files IND for Phase 3 trial of BARYCELA in Thailand

Novavax COVID-19 vaccine approved in US

WHO and UNICEF deploy PharmaJet's Tropis ID system in Afghanistan polio campaign

FDA grants priority review for GSK's gepotidacin gonorrhoea indication

GSK to receive USD370m and future royalties in CureVac/BioNTech settlement

ViruSure and Oxford Nanopore launch first nanopore-based viral contamination test for biomanufacturing

FDA lifts pause on Valneva's chikungunya vaccine IXCHIQ for elderly, updates prescribing information

Anixa Biosciences begins US FDA approved IND transfer to support Phase 2 breast cancer vaccine trial

Pfizer and BioNTech receive EU regulatory backing for LP.8.1-adapted COVID-19 vaccine

Sanofi to acquire Vicebio for USD1.15bn to strengthen respiratory vaccine pipeline

Bavarian Nordic chikungunya vaccine enters Health Canada review process